Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tatnic who wrote (6344)	4/10/1999 7:37:00 PM
From: VLAD	Read Replies (1) \| Respond to of 7041

The fundamentals on the product have long been known but that doesn't mean they won't run this POS up to the 30's one more time. Starting in early 1998 this POS made a run to 40 on no fundamental change. Then it dropped down to the mid teens last fall only to make another run to the mid thirties early this year. And now here we go back down again. A lot of money could have been made trading this sardine properly but sooner or later the fundamentals catch up. I believe that either the share price will soon drop to a new 52 week low and then hit single digits or else it will make another hot air run north if and when Vasomax gets FDA approval. But remember, the bottom line is that the stuff only works in men with mild ED and they will probably prefer a more effective drug (Viagra) as opposed to using a marginally effective drug. Zonagen is a story stock and IMO the story is nearing its end.